跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
T Cells - Tisagenlecleucel, cryopreserved - T - Kymriah - TGA Drug Approval Details
Approvals
/
TGA
/
T Cells - Tisagenlecleucel, cryopreserved - T - Kymriah
Approved
STANDARD
T Cells - Tisagenlecleucel, cryopreserved - T - Kymriah
Novartis Pharmaceuticals Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
ff3663d57166ef19
Company
Novartis Pharmaceuticals Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
ff3663d57166ef19
Product Name
T Cells - Tisagenlecleucel, cryopreserved - T - Kymriah
Artg Id
475976
Artg Name
Cellular Therapies - T Cells - Tisagenlecleucel, cryopreserved - T - Kymriah - Novartis Pharmaceuticals Australia Pty Ltd - Suspension - Bag
Sponsor
Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path
/organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date
2025-01-16
Registration Type
Biological
Therapeutic Good Type
Biological
Licence Status
A
Licence Category
INC
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/c5ff9c88d31744a64967fab956ce2c10.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/8644b7b92362491f79d24dda6e8358fb.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
ff3663d57166ef19
Type
Standard
Back to TGA Approvals
